Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro
Tóm tắt
Neural stem cells from neurogenic regions of mammalian CNS are clonogenic in an in vitro culture system exploiting serum and anchorage withdrawal in medium supplemented with methyl cellulose and the pleiotropic growth factors EGF, FGF2, and insulin. The aim of this study was to test whether cortical glial tumors contain stem‐like cells capable, under this culture system, of forming clones showing intraclonal heterogeneity in the expression of neural lineage‐specific proteins. The high frequencies of clone‐forming cells (about 0.1–10 × 10−3) in clinical tumor specimens with mutated p53, and in neurogenic regions of normal human CNS, suggest that the ability to form clones in this culture system is induced epigenetically. RT‐PCR analyses of populations of normal brain‐ and tumor‐derived sister clones revealed transcripts for nestin, neuron‐specific enolase, and glial fibrillary acidic protein (GFAP). However, the tumor‐derived clones were different from clones derived from neurogenic regions of normal brain in the expression of transcripts specific for genes associated with neural cell fate determination via the
Từ khóa
Tài liệu tham khảo
Adida C, 1998, Developmentally regulated expression of the novel cancer anti‐apoptosis gene Survivin in human and mouse differentiation, Am J Pathol, 152, 43
Dahlstrand J, 1992, Expression of the class VI intermediate filament nestin in human central nervous system tumors, Cancer Res, 52, 5334
Eaves CJ, 1995, Hematology, 122
Mahotka C, 1999, Survivin‐AEx3 and survivin‐2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties, Cancer Res, 59, 6098
Uhrbum L, 1998, Induction of brain tumors in mice using a recombinant platelet‐derived growth factor B‐chain retrovirus, Cancer Res, 58, 5275
Zhang T, 2001, Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer, Cancer Res, 62, 8664